Please login to the form below

Not currently logged in
Email:
Password:

Juventas

This page shows the latest Juventas news and features for those working in and with pharma, biotech and healthcare.

Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal

Astellas bulks up immuno-oncology pipeline with $665m Xyphos deal

This includes a deal made in  2018, when Astellas bought out gene therapy biotech Juventas for an exclusive option on its non-viral gene therapy JVS-100.

Latest news

  • Astellas makes another gene therapy play with Juventas deal Astellas makes another gene therapy play with Juventas deal

    Targeting faecal incontinence, which affects 50m worldwide. Astellas has made another deal in the gene therapy category, licensing a candidate for treating faecal incontinence from US biotech Juventas Therapeutics. ... Juventas has previously shown that

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Heart failure therapy embarks on a new era Heart failure therapy embarks on a new era

    Among these, Juventas Therapeutics' non-viral gene therapy JVS-100 - which expresses stromal cell-derived factor-1 (SDF-1) and activates the body's own tissue repair pathways - has been

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics